Lista de obras - Lizza Hendriks - Dominio Público Uruguay

An Uncommon Presentation of Brain Metastases in a Lung Cancer Patient.

artículo científico publicado en 2015

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer

artículo científico publicado en 2018

Are We Ready to Safely Combine Anti-PD-1/PD-L1 with Cranial Irradiation in Non-Small Cell Lung Cancer Patients?

artículo científico publicado en 2018

Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer

artículo científico publicado en 2018

Brain imaging in early stage non-small cell lung cancer: still a controversial topic?

scientific article published on 01 July 2018

Circulating T-cell immunosenescence in advanced non-small cell lung cancer patients treated with single agent PD-1/PD-L1 inhibitors or platinum-based chemotherapy

scientific article published on 04 September 2020

Clinical features of large cell neuroendocrine carcinoma: a population-based overview.

artículo científico publicado en 2015

Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy

scientific article published on 01 December 2018

Combination treatments with immunotherapy in brain metastases patients

artículo científico publicado en 2020

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

artículo científico publicado en 2015

Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoring

artículo científico publicado en 2018

Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

artículo científico publicado en 2016

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2017

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey

artículo científico publicado en 2018

EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?

artículo científico publicado en 2014

Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.

artículo científico publicado en 2016

Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment

artículo científico publicado en 2018

External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy

scientific article published on 18 September 2018

Heat shock protein antagonists in early stage clinical trials for NSCLC.

artículo científico publicado en 2017

Hyperthyroidism caused by excessive consumption of sausages

scientific article published on 01 March 2010

Immune checkpoint inhibitors in non-small-cell lung cancer: key to long-term survival?

scientific article published on 12 March 2019

Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?

scientific article published on 15 October 2018

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer

scientific article published on 20 August 2018

Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)

scientific article published on 30 September 2020

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

scientific article published on 27 March 2019

Invasive Aspergillosis Mimicking Metastatic Lung Cancer.

artículo científico publicado en 2018

Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?

artículo científico publicado en 2019

Lung cancer in idiopathic pulmonary fibrosis patients diagnosed during or after lung transplantation.

artículo científico publicado en 2012

New windows open for immunotherapy in lung cancer

artículo científico publicado en 2018

Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment

article

Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

scientific article published on 16 February 2019

Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.

artículo científico publicado en 2014

Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

scientific article published on 22 September 2018

Prospects of targeted and immune therapies in SCLC.

artículo científico publicado en 2018

Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators

artículo científico publicado en 2019

Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: A systematic review.

artículo científico

Screening for Brain Metastases in Resectable Non-Small Cell Lung Cancer

artículo científico publicado en 2017

Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?

artículo científico publicado en 2013

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study

artículo científico publicado en 2015

Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.

artículo científico publicado en 2016

Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions.

artículo científico publicado en 2018

Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer ⬇️

artículo científico publicado en 2023

The Current Role of Whole Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients.

artículo científico publicado en 2017

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation ⬇️

artículo científico publicado en 2018

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

artículo científico publicado en 2015

Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.

artículo científico publicado en 2017

What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer

scientific article published on 18 July 2018

Lista de obras de Lizza Hendriks

An Uncommon Presentation of Brain Metastases in a Lung Cancer Patient.

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer

Are We Ready to Safely Combine Anti-PD-1/PD-L1 with Cranial Irradiation in Non-Small Cell Lung Cancer Patients?

Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer

Brain imaging in early stage non-small cell lung cancer: still a controversial topic?

Circulating T-cell immunosenescence in advanced non-small cell lung cancer patients treated with single agent PD-1/PD-L1 inhibitors or platinum-based chemotherapy

Clinical features of large cell neuroendocrine carcinoma: a population-based overview.

Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy

Combination treatments with immunotherapy in brain metastases patients

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoring

Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey

EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?

Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.

Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment

External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy

Heat shock protein antagonists in early stage clinical trials for NSCLC.

Hyperthyroidism caused by excessive consumption of sausages

Immune checkpoint inhibitors in non-small-cell lung cancer: key to long-term survival?

Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer

Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

Invasive Aspergillosis Mimicking Metastatic Lung Cancer.

Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?

Lung cancer in idiopathic pulmonary fibrosis patients diagnosed during or after lung transplantation.

New windows open for immunotherapy in lung cancer

Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment

Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.

Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

Prospects of targeted and immune therapies in SCLC.

Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators

Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: A systematic review.

Screening for Brain Metastases in Resectable Non-Small Cell Lung Cancer

Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study

Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.

Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions.

Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer ⬇️

The Current Role of Whole Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients.

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation ⬇️

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.

What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer